ReviewCureus2024

Recent Advances and Therapeutic Benefits of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Management of Type 2 Diabetes and Associated Metabolic Disorders.

John O Olukorode et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.